{"pmid":32442261,"title":"Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17.","text":["Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17.","Influenza vaccine effectiveness against influenza and non-influenza respiratory viruses (NIRV) was assessed by test-negative design using historic datasets of the community-based Canadian Sentinel Practitioner Surveillance Network (SPSN), spanning 2010-11 to 2016-17. Vaccine significantly reduced the risk of influenza illness by >40% with no effect on coronaviruses or other NIRV risk.","Clin Infect Dis","Skowronski, Danuta M","Zou, Macy","Clarke, Quinten","Chambers, Catharine","Dickinson, James A","Sabaiduc, Suzana","Olsha, Romy","Gubbay, Jonathan B","Drews, Steven J","Charest, Hugues","Winter, Anne-Luise","Jassem, Agatha","Murti, Michelle","Krajden, Mel","De Serres, Gaston","32442261"],"abstract":["Influenza vaccine effectiveness against influenza and non-influenza respiratory viruses (NIRV) was assessed by test-negative design using historic datasets of the community-based Canadian Sentinel Practitioner Surveillance Network (SPSN), spanning 2010-11 to 2016-17. Vaccine significantly reduced the risk of influenza illness by >40% with no effect on coronaviruses or other NIRV risk."],"journal":"Clin Infect Dis","authors":["Skowronski, Danuta M","Zou, Macy","Clarke, Quinten","Chambers, Catharine","Dickinson, James A","Sabaiduc, Suzana","Olsha, Romy","Gubbay, Jonathan B","Drews, Steven J","Charest, Hugues","Winter, Anne-Luise","Jassem, Agatha","Murti, Michelle","Krajden, Mel","De Serres, Gaston"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442261","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/cid/ciaa626","keywords":["coronavirus","influenza","non-specific immunity","respiratory viruses","vaccine effectiveness"],"locations":["Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Treatment"],"weight":1,"_version_":1667523504889659392,"score":9.490897,"similar":[{"pmid":32399192,"pmcid":"PMC7194468","title":"Recent advances in influenza vaccines.","text":["Recent advances in influenza vaccines.","Seasonal influenza remains a major public health problem, responsible for hundreds of thousands of deaths every year, mostly of elderly people. Despite the wide availability of vaccines, there are multiple problems decreasing the effectiveness of vaccination programs. These include viral variability and hence the requirement to match strains by estimating which will become prevalent each season, problems associated with vaccine and adjuvant production, and the route of administration as well as the perceived lower vaccine efficiency in older adults. Clinical protection is still suboptimal for all of these reasons, and vaccine uptake remains too low in most countries. Efforts to improve the effectiveness of influenza vaccines include developing universal vaccines independent of the circulating strains in any particular season and stimulating cellular as well as humoral responses, especially in the elderly. This commentary assesses progress over the last 3 years towards achieving these aims. Since the beginning of 2020, an unprecedented international academic and industrial effort to develop effective vaccines against the new coronavirus SARS-CoV-2 has diverted attention away from influenza, but many of the lessons learned for the one will synergize with the other to mutual advantage. And, unlike the SARS-1 epidemic and, we hope, the SARS-CoV-2 pandemic, influenza will not be eliminated and thus efforts to improve influenza vaccines will remain of crucial importance.","F1000Res","Pawelec, Graham","McElhaney, Janet","32399192"],"abstract":["Seasonal influenza remains a major public health problem, responsible for hundreds of thousands of deaths every year, mostly of elderly people. Despite the wide availability of vaccines, there are multiple problems decreasing the effectiveness of vaccination programs. These include viral variability and hence the requirement to match strains by estimating which will become prevalent each season, problems associated with vaccine and adjuvant production, and the route of administration as well as the perceived lower vaccine efficiency in older adults. Clinical protection is still suboptimal for all of these reasons, and vaccine uptake remains too low in most countries. Efforts to improve the effectiveness of influenza vaccines include developing universal vaccines independent of the circulating strains in any particular season and stimulating cellular as well as humoral responses, especially in the elderly. This commentary assesses progress over the last 3 years towards achieving these aims. Since the beginning of 2020, an unprecedented international academic and industrial effort to develop effective vaccines against the new coronavirus SARS-CoV-2 has diverted attention away from influenza, but many of the lessons learned for the one will synergize with the other to mutual advantage. And, unlike the SARS-1 epidemic and, we hope, the SARS-CoV-2 pandemic, influenza will not be eliminated and thus efforts to improve influenza vaccines will remain of crucial importance."],"journal":"F1000Res","authors":["Pawelec, Graham","McElhaney, Janet"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399192","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12688/f1000research.22611.1","keywords":["adjuvant","effectiveness","elderly","influenza","vaccine"],"topics":["Treatment"],"weight":1,"_version_":1666714494960664576,"score":175.57808},{"pmid":32419400,"title":"Social Distancing against COVID-19: Implication for the Control of Influenza.","text":["Social Distancing against COVID-19: Implication for the Control of Influenza.","Social distancing has been adopted as one of basic protective measures against coronavirus disease 2019 (COVID-19). During 2019-2020 season, influenza epidemic period was exceptionally short and epidemic peak was low in comparison with previous seasons in Korea. Influenza epidemic pattern was bimodal in 2016-2017 and 2018-2019 seasons, however, influenza viruses have rarely been circulating in spring, 2020 in Korea. Although multiple factors could affect the size of influenza epidemic, extensive application of nonpharmaceutical interventions including mask wearing and social distancing in response to COVID-19 seems to be a major factor of reduced influenza epidemic. Social distancing measures with high feasibility and high acceptability should be implemented even if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are developed in the future. Establishment of guideline for workplace social distancing is needed and it would contribute to reduce disease burden of influenza, especially in vaccine mismatch year.","J Korean Med Sci","Noh, Ji Yun","Seong, Hye","Yoon, Jin Gu","Song, Joon Young","Cheong, Hee Jin","Kim, Woo Joo","32419400"],"abstract":["Social distancing has been adopted as one of basic protective measures against coronavirus disease 2019 (COVID-19). During 2019-2020 season, influenza epidemic period was exceptionally short and epidemic peak was low in comparison with previous seasons in Korea. Influenza epidemic pattern was bimodal in 2016-2017 and 2018-2019 seasons, however, influenza viruses have rarely been circulating in spring, 2020 in Korea. Although multiple factors could affect the size of influenza epidemic, extensive application of nonpharmaceutical interventions including mask wearing and social distancing in response to COVID-19 seems to be a major factor of reduced influenza epidemic. Social distancing measures with high feasibility and high acceptability should be implemented even if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are developed in the future. Establishment of guideline for workplace social distancing is needed and it would contribute to reduce disease burden of influenza, especially in vaccine mismatch year."],"journal":"J Korean Med Sci","authors":["Noh, Ji Yun","Seong, Hye","Yoon, Jin Gu","Song, Joon Young","Cheong, Hee Jin","Kim, Woo Joo"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419400","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3346/jkms.2020.35.e182","keywords":["coronavirus disease 2019","influenza","social distancing"],"locations":["South Korea","South Korea","vaccine"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Prevention"],"weight":1,"_version_":1667254896787718144,"score":166.59366},{"pmid":32294922,"title":"Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review.","text":["Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review.","A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, \"Exercise,\" \"Older adult,\" \"Influenza,\" and \"Pneumonia.\" Any randomized control trials, cross-sectional and observational studies that related to this topic were all included. Twenty studies met the eligibility criteria for this review. Thirteen randomized control trials investigated the effects of exercise on the immune responses to influenza or pneumonia vaccination: seven trials employed moderate aerobic exercise, three employed resistance exercise, and the remaining three used Asian martial arts or special home-based exercises. Five cross-sectional and two observational studies examined the associations between exercise/physical condition and influenza/pneumonia. Most of the current studies suggested that prolonged moderate aerobic exercise may help to reduce the risk of influenza-related infection and improve the immune responses to influenza or pneumonia vaccination in older adults. In addition, training in traditional Asian martial arts was also found to be beneficial. Future research should focus on the different effects of moderate and vigorous exercise on influenza-related diseases.","Int J Environ Res Public Health","Song, Yang","Ren, Feng","Sun, Dong","Wang, Meizi","Baker, Julien S","Istvan, Biro","Gu, Yaodong","32294922"],"abstract":["A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, \"Exercise,\" \"Older adult,\" \"Influenza,\" and \"Pneumonia.\" Any randomized control trials, cross-sectional and observational studies that related to this topic were all included. Twenty studies met the eligibility criteria for this review. Thirteen randomized control trials investigated the effects of exercise on the immune responses to influenza or pneumonia vaccination: seven trials employed moderate aerobic exercise, three employed resistance exercise, and the remaining three used Asian martial arts or special home-based exercises. Five cross-sectional and two observational studies examined the associations between exercise/physical condition and influenza/pneumonia. Most of the current studies suggested that prolonged moderate aerobic exercise may help to reduce the risk of influenza-related infection and improve the immune responses to influenza or pneumonia vaccination in older adults. In addition, training in traditional Asian martial arts was also found to be beneficial. Future research should focus on the different effects of moderate and vigorous exercise on influenza-related diseases."],"journal":"Int J Environ Res Public Health","authors":["Song, Yang","Ren, Feng","Sun, Dong","Wang, Meizi","Baker, Julien S","Istvan, Biro","Gu, Yaodong"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32294922","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3390/ijerph17082655","keywords":["exercise","influenza","older adults","pneumonia"],"locations":["Pneumonia"],"topics":["Prevention"],"weight":1,"_version_":1666138493341925376,"score":147.47693},{"pmid":32397182,"title":"Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development.","text":["Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development.","In the midst of the ongoing COVID-19 coronavirus pandemic, influenza virus remains a major threat to public health due to its potential to cause epidemics and pandemics with significant human mortality. Cases of H7N9 human infections emerged in eastern China in 2013 and immediately raised pandemic concerns as historically, pandemics were caused by the introduction of new subtypes into immunologically naive human populations. Highly pathogenic H7N9 cases with severe disease were reported recently, indicating the continuing public health threat and the need for a prophylactic vaccine. Here we review the development of recombinant influenza virus-like particles (VLPs) as vaccines against H7N9 virus. Several approaches to vaccine development are reviewed including the expression of VLPs in mammalian, plant and insect cell expression systems. Although considerable progress has been achieved, including demonstration of safety and immunogenicity of H7N9 VLPs in the human clinical trials, the remaining challenges need to be addressed. These challenges include improvements to the manufacturing processes, as well as enhancements to immunogenicity in order to elicit protective immunity to multiple variants and subtypes of influenza virus.","Viruses","Pushko, Peter","Tretyakova, Irina","32397182"],"abstract":["In the midst of the ongoing COVID-19 coronavirus pandemic, influenza virus remains a major threat to public health due to its potential to cause epidemics and pandemics with significant human mortality. Cases of H7N9 human infections emerged in eastern China in 2013 and immediately raised pandemic concerns as historically, pandemics were caused by the introduction of new subtypes into immunologically naive human populations. Highly pathogenic H7N9 cases with severe disease were reported recently, indicating the continuing public health threat and the need for a prophylactic vaccine. Here we review the development of recombinant influenza virus-like particles (VLPs) as vaccines against H7N9 virus. Several approaches to vaccine development are reviewed including the expression of VLPs in mammalian, plant and insect cell expression systems. Although considerable progress has been achieved, including demonstration of safety and immunogenicity of H7N9 VLPs in the human clinical trials, the remaining challenges need to be addressed. These challenges include improvements to the manufacturing processes, as well as enhancements to immunogenicity in order to elicit protective immunity to multiple variants and subtypes of influenza virus."],"journal":"Viruses","authors":["Pushko, Peter","Tretyakova, Irina"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397182","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/v12050518","keywords":["h7n9","iav","vlp vaccine","avian flu","pandemic influenza a"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666714494948081664,"score":146.88637},{"pmid":32492532,"pmcid":"PMC7261472","title":"Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020.","text":["Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020.","OBJECTIVES: Infection due to the 2019 novel coronavirus disease (COVID-19) is widespread dramatically around the world. This COVID-19 pandemic could increase public concern to prevent infectious disease. The present study aimed to assess the relationship between the COVID-19 epidemic and decreasing another infectious disease. METHODS: This study was performed to show trends in seasonal influenza cases from the 2014-2015 season to the 2019-2020 season in 11 countries and regions, and evaluate whether the trends in the 2019-2020 season were different before and after the COVID-19 pandemic compared to previous seasons using a quasi-experimental difference-in-difference design. RESULTS: In East Asia, the number of seasonal influenza cases in the 2019-20 season was lower after the COVID-19 transmission compared to previous years. However, this was not the case in the American countries or in European countries. CONCLUSION: The COVID-19 epidemic might have altered health behaviors, resulting in an unexpected reduction of seasonal influenza cases.","Int J Infect Dis","Itaya, Takahiro","Furuse, Yuki","Jindai, Kazuaki","32492532"],"abstract":["OBJECTIVES: Infection due to the 2019 novel coronavirus disease (COVID-19) is widespread dramatically around the world. This COVID-19 pandemic could increase public concern to prevent infectious disease. The present study aimed to assess the relationship between the COVID-19 epidemic and decreasing another infectious disease. METHODS: This study was performed to show trends in seasonal influenza cases from the 2014-2015 season to the 2019-2020 season in 11 countries and regions, and evaluate whether the trends in the 2019-2020 season were different before and after the COVID-19 pandemic compared to previous seasons using a quasi-experimental difference-in-difference design. RESULTS: In East Asia, the number of seasonal influenza cases in the 2019-20 season was lower after the COVID-19 transmission compared to previous years. However, this was not the case in the American countries or in European countries. CONCLUSION: The COVID-19 epidemic might have altered health behaviors, resulting in an unexpected reduction of seasonal influenza cases."],"journal":"Int J Infect Dis","authors":["Itaya, Takahiro","Furuse, Yuki","Jindai, Kazuaki"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492532","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.088","keywords":["covid-19","health behavior","human","influenza","pandemics"],"locations":["American"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668892169302179840,"score":144.83336}]}